Arizona Department of Health Services Home Page Banner
 
Administrative Rules Home
   
Office of Administrative Rules
Agency Guidance Documents
 
Pursuant to A.R.S. § 41-1013, notices of the following agency guidance documents have been published in the Arizona Administrative Register.  

You may access a notice on the Secretary of State's web site by clicking on the Register Citation. You may have to page through other agency materials to find the Department of Health Services' notice of agency guidance documents. The notice contains the effective date of the guidance document but does not include the guidance document.

To access an agency guidance document, click on the PDF or WORD links for "Guidance Document" under the title of the appropriate agency guidance document.  Acrobat Reader is required to open a document in PDF format. 

  
Division of Public Health Services
  
GD-086-PHS-EMS:  Drug Profile for Ranitidine
Notice of Agency Guidance Documents Guidance Document

13 AAR 597

[PDF 19K] [WORD 28K]
  
GD-085-PHS-EMS:  Drug Profile for Famotidine
Notice of Agency Guidance Documents Guidance Document

13 AAR 596

[PDF 19K] [WORD 28K]
  
GD-084-PHS-EMS:  Drug Profile for Cimetidine
Notice of Agency Guidance Documents Guidance Document

13 AAR 595

[PDF 28K] [WORD 28K]
  
GD-083-PHS-EMS:  Drug Profile for Lorazepam
Notice of Agency Guidance Documents Guidance Document

13 AAR 594

[PDF 29K] [WORD 28K]
  
GD-082-PHS-EMS:  Drug Profile for Racemic Epinephrine
Notice of Agency Guidance Documents Guidance Document

13 AAR 593

[PDF 28K] [WORD 27K]
  
GD-081-PHS-EMS:  Recommendations for EMT-B Use of an Esophageal Tracheal Double Lumen Airway Device (ETDLAD)
Notice of Agency Guidance Documents Guidance Document

11 AAR 4995

[PDF 22K] [WORD 30K]
  
GD-080-PHS-EMS:  Drug Profile for Vasopressin
Notice of Agency Guidance Documents Guidance Document

11 AAR 4995

[PDF 22K] [WORD 23K]
  
GD-079-PHS-EMS:  Triage and Treatment Protocol for Pediatric Bradycardia, Unstable
Notice of Agency Guidance Documents Guidance Document

13 AAR 593

[PDF 20K] [WORD 54K]
  
GD-078-PHS-EMS:  Triage and Treatment Protocol for Pediatric Anaphylaxis/Allergic Reaction
Notice of Agency Guidance Documents Guidance Document

13 AAR 592

[PDF 22K] [WORD 57K]
  
GD-077-PHS-EMS:  Triage and Treatment Protocol for Newborn Resuscitation
Notice of Agency Guidance Documents Guidance Document

13 AAR 591

[PDF 23K] [WORD 61K]
  
GD-076-PHS-EMS:  Triage and Treatment Protocol for Pediatric Pulseless Electrical Activity (PEA)/Asystole
Notice of Agency Guidance Documents Guidance Document

13 AAR 590

[PDF 23K] [WORD 59K]
  
GD-075-PHS-EMS:  Triage and Treatment Protocol for Pediatric Seizures
Notice of Agency Guidance Documents Guidance Document

13 AAR 589

[PDF 20K] [WORD 55K]
  
GD-074-PHS-EMS:  Triage and Treatment Protocol for Pediatric Altered Mental Status
Notice of Agency Guidance Documents Guidance Document

13 AAR 588

[PDF 19K] [WORD 53K]
  
GD-073-PHS-EMS:  Triage and Treatment Protocol for Pediatric Shock
Notice of Agency Guidance Documents Guidance Document

13 AAR 587

[PDF 19K] [WORD 52K]
  
GD-072-PHS-EMS:  Triage and Treatment Protocol for Pediatric Submersion Injury
Notice of Agency Guidance Documents Guidance Document

13 AAR 586

[PDF 20K] [WORD 53K]
  
GD-071-PHS-EMS:  Triage and Treatment Protocol for Pediatric Ventricular Fibrillation/Pulseless Ventricular Tachycardia
Notice of Agency Guidance Documents Guidance Document

13 AAR 586

[PDF 22K] [WORD 55K]
  
GD-070-PHS-EMS:  Triage and Treatment Protocol for Pediatric Supraventricular Tachycardia
Notice of Agency Guidance Documents Guidance Document

13 AAR 585

[PDF 24K] [WORD 59K]
  
GD-069-PHS-EMS:  Drug Profile for Succinylcholine
Notice of Agency Guidance Documents Guidance Document

11 AAR 3262

[PDF 17K] [WORD 24K]
  
GD-068-PHS-EMS:  Drug Profile for Etomidate
Notice of Agency Guidance Documents Guidance Document

11 AAR 3262

[PDF 15K] [WORD 22K]
  
GD-067-PHS-EMS:  Recommendations for EMT-P Performance of Rapid Sequence Intubation (RSI) in the Prehospital EMS Environment
Notice of Agency Guidance Documents Guidance Document

11 AAR 3262

[PDF 74K] [WORD 77K]
  
GD-066-PHS-EMS:  Drug Profile for EMT-B Administration of Aspirin
Notice of Agency Guidance Documents Guidance Document

11 AAR 2406

[PDF 17K] [WORD 26K]
  
GD-065-PHS-EMS:  Drug Profile for Epinephrine Auto-Injector
Notice of Agency Guidance Documents Guidance Document

11 AAR 2405

[PDF 29K] [WORD 25K]
  
GD-064-PHS-EMS:  Arizona Trauma Patient Identification & Field Triage Decision Standard
Notice of Agency Guidance Documents Guidance Document

13 AAR 1752

[PDF 233K]
  
GD-063-PHS-EMS:  Drug Profile for Nalmefene HCl
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 19K] [WORD 23K]
  
GD-062-PHS-EMS:  Drug Profile for Total Parenteral Nutrition
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 16K] [WORD 26K]
  
GD-061-PHS-EMS:  Drug Profile for Tirofiban
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 21K] [WORD 31K]
  
GD-060-PHS-EMS:  Drug Profile for Eptifibatide
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 22K] [WORD 31K]
  
GD-059-PHS-EMS:  Drug Profile for Diltiazem
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 22K] [WORD 25K]
  
GD-058-PHS-EMS:  Drug Profile for Albumin, normal serum 5% or 25%
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 15K] [WORD 25K]
  
GD-057-PHS-EMS:  Drug Profile for Abciximab
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 22K] [WORD 29K]
  
GD-056-PHS-EMS:  Drug Profile for Verapamil HCl
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 20K] [WORD 28K]
  
GD-055-PHS-EMS:  Drug Profile for Thiamine HCl (vitamin B1)
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 16K] [WORD 25K]
  
GD-054-PHS-EMS:  Drug Profile for Sodium Bicarbonate 8.4%
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 29K]
  
GD-053-PHS-EMS:  Drug Profile for Phenylephrine Nasal Spray 0.5%
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 16K] [WORD 24K]
  
GD-052-PHS-EMS:  Drug Profile for Oxytocin
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 27K]
  
GD-051-PHS-EMS:  Drug Profile for Nitrous Oxide 50%
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 25K]
  
GD-050-PHS-EMS:  Drug Profile for Nitroglycerin
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 19K] [WORD 28K]
  
GD-049-PHS-EMS:  Drug Profile for Naloxone HCl
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 27K]
  
GD-048-PHS-EMS:  Drug Profile for Morphine Sulfate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 26K]
  
GD-047-PHS-EMS:  Drug Profile for Midazolam Hydrochloride
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 20K] [WORD 32K]
  
GD-046-PHS-EMS:  Drug Profile for Methylprednisolone Sodium Succinate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 18K] [WORD 26K]
  
GD-045-PHS-EMS:  Drug Profile for Magnesium Sulfate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 23K] [WORD 31K]
  
GD-044-PHS-EMS:  Drug Profile for Lidocaine HCl
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 20K] [WORD 30K]
  
GD-043-PHS-EMS:  Drug Profile for Ipratropium Bromide
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 15K] [WORD 25K]
  
GD-042-PHS-EMS:  Drug Profile for Glucagon
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 18K] [WORD 26K]
  
GD-041-PHS-EMS:  Drug Profile for Furosemide
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 25K]
  
GD-040-PHS-EMS:  Drug Profile for Epinephrine HCl
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 24K] [WORD 33K]
  
GD-039-PHS-EMS:  Drug Profile for Dopamine
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 36K] [WORD 27K]
  
GD-038-PHS-EMS:  Drug Profile for Diphenhydramine HCl
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 26K]
  
GD-037-PHS-EMS:  Drug Profile for Diazepam
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 24K] [WORD 27K]
  
GD-036-PHS-EMS:  Drug Profile for Dextrose 50%
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 19K] [WORD 27K]
  
GD-035-PHS-EMS:  Drug Profile for Dexamethasone Sodium Phosphate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 19K] [WORD 24K]
  
GD-034-PHS-EMS:  Drug Profile for Charcoal, Activated (without sorbitol)
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 26K]
  
GD-033-PHS-EMS:  Drug Profile for Calcium Chloride
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 26K]
  
GD-032-PHS-EMS:  Drug Profile for Bumetanide
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 16K] [WORD 22K]
  
GD-031-PHS-EMS:  Drug Profile for Bretylium Tosylate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 26K]
  
GD-030-PHS-EMS:  Drug Profile for Atrophine Sulfate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 19K] [WORD 28K]
  
GD-029-PHS-EMS:  Drug Profile for Amiodarone
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 74K] [WORD 25K]
  
GD-028-PHS-EMS:  Drug Profile for Albuterol Sulfate
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 16K] [WORD 25K]
  
GD-027-PHS-EMS:  Drug Profile for Adenosine
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 20K] [WORD 28K]
  
GD-026-PHS-EMS:  Drug Profile for Acetylsalicylic Acid, Aspirin, ASA
Notice of Agency Guidance Documents Guidance Document

11 AAR 1118

[PDF 17K] [WORD 26K]

ADHS Web Privacy Policy. This page last modified on May 21, 2007.
Copyright 2007 Arizona Department of Health Services. All rights reserved.
General comments, questions, or concerns:  ADHS Webmaster